Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001209191-23-007513

Options or other derivatives

  • President and CEO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wolchko J Scott President and CEO 2023-02-06 Grant or award · Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X03/doc4.xml…